Medical Services Expenditures by Disease: Diseases of the Respiratory System, Blended Account Basis (DIRESYEXPBLEND) | FRED | St. Louis Fed
- Rows
- 22
- Columns
- 2
- Data range
- 2000-01-01 to 2021-01-01
Graph and download economic data for Medical Services Expenditures by Disease: Diseases of the Respiratory System, Blended Account Basis (DIRESYEXPBLEND) from 2000 to 2021 about respiratory, disease, healthcare, medical, health, expenditures, services, and USA.
AI analysis
Dataset Analysis: Medical Services Expenditures — Diseases of the Respiratory System (DIRESYEXPBLEND)
1. What this dataset represents
This series, sourced from the St. Louis Fed's FRED API (fredgraph.csv?id=DIRESYEXPBLEND), tracks annual medical services expenditures attributable to respiratory disease treatment in the U.S. on a "blended account basis" — a methodology that typically combines multiple payer/accounting perspectives (e.g., out-of-pocket, insurance, public programs) into a single expenditure estimate. Covering 2000–2021 as a low-frequency (annual) time series, it's a compact but valuable input for longitudinal healthcare cost studies. Since FRED aggregates and republishes data from primary statistical agencies (in this case likely derived from CMS/BEA health expenditure accounts), the series benefits from the Fed's standardized formatting and reliability, though the 2021 endpoint suggests it is not frequently updated — users should check FRED directly for more recent vintages before assuming currency.
2. Data quality observations
Data quality here is excellent at face value: zero null cells across both columns, and each of the 22 rows has a fully populated date and value. Distinct counts (22 for both columns) confirm one clean, non-duplicated observation per year with no repeated timestamps — a well-formed time series with no evident type mismatches. The duplicate-row check is marked as pending Phase D recomputation, so that figure should be verified before final certification, but nothing in the current metadata suggests hidden duplication risk given the perfect distinct-count alignment with row count.
3. Key columns and distributions
The dataset has only two columns: observationdate (join key, annual) and DIRESYEXPBLEND (the expenditure metric). The expenditure values range from a minimum of 91.98 to a maximum of 174.01, with a mean of 137.08 and median of 141.9 — the mean sitting below the median, consistent with the mild negative skew (-0.406), indicating a somewhat longer left tail (likely reflecting lower expenditure values concentrated in the earlier 2000s before costs climbed). The interquartile range (Q1=124.6, Q3=149.16) shows that the middle 50% of observations cluster within a relatively narrow ~24.5-point band, while the standard deviation of 22.78 relative to the mean suggests moderate year-to-year variability — plausible for a 22-year span capturing inflation, policy shifts (e.g., ACA implementation ~2010–2014), and pandemic-related respiratory care shifts in 2020–2021.
4. Recommended join key
observationdate is the clear and only viable join key, given its annual granularity and zero nulls/full distinctness. Analysts should align this to January 1 (or year-only) timestamps in any dataset being merged, and consider resampling higher-frequency datasets (monthly/quarterly) down to annual before joining to avoid aggregation mismatches.
5. Suggested pairings for correlation analysis
This series pairs naturally with: (a) other FRED disease-expenditure series (e.g., cardiovascular, cancer, or infectious disease expenditure accounts) to compare relative cost trajectories; (b) CPI for Medical Care or CPI subcomponents for hospital/respiratory-related services, to distinguish price inflation from utilization growth; (c) air quality / pollution indices (e.g., EPA AQI, PM2.5 data) to test environmental drivers of respiratory costs; (d) influenza/COVID-19 case and hospitalization data (CDC) especially around the 2020–2021 tail; and (e) health insurance coverage rates or Medicare/Medicaid enrollment data to contextualize expenditure growth against population coverage changes. Given the short annual series (n=22), correlation analyses should be mindful of limited statistical power and potential confounding from broad macroeconomic trends (e.g., overall healthcare inflation) rather than disease-specific effects alone.
Columns
- observation_date (date)
- DIRESYEXPBLEND (decimal)